Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

Table 4 Multivariate analysis of the predictors for failure in clinical resolution

Variables	Adjusted OR (95% CI)	p
CURB65 score	0.65 (0.35–1.23)	0.187
Mechanical ventilation	0.33 (0.07–1.59)	0.165
Bacteremia	0.21 (0.02–2.46)	0.213
Airway eradication of MDRAB	1.45 (0.63–3.34)	0.382
Duration of Tigecycline treatment	1.23 (1.02–1.48)	0.031
Delayed tigecycline treatment	3.60 (0.62–20.90)	0.153

Abbreviations: OR odd ratio, CI confidence interval, MDRAB multidrugresistant Acinetobacter baumannii
^aCategorical data are n (%) of subject, continuous data are expressed as mean (standard deviation)

ISSN: 2050-6511